Institut für Pharmazeutische und Medizinische Chemie der Universität Münster, Hittorfstrasse 58-62, D-48149 Münster, Germany.
Org Biomol Chem. 2010 Jan 7;8(1):212-25. doi: 10.1039/b915180j. Epub 2009 Nov 12.
Reductive amination of the bicyclic ketone 4 led diastereoselectively to endo-configured amines, which were transformed into the amides 7-10. The synthesis of the diastereomers 25 with an exo-configured amino moiety at position 6 was only successful after deactivation of both N-atoms of the 1,4-diazabicyclo[3.3.1]nonane system. The N-1-oxide 19 with an N-4-tosyl moiety was the crucial intermediate, which allows SN2 substitution with NaN3 under inversion of the configuration at position 6. Whereas the endo-configured pyrrolidine 7a (WMS-1302) revealed a kappa receptor affinity of 73 nM, the exo-configured diastereomer 25a was almost inactive at the kappa receptor (Ki > 1 microM). Replacement of the 3,4-dichlorophenylacetyl residue by other acyl and sulfonyl residues showed that it is essential for high kappa affinity. The kappa receptor affinities of the conformationally constrained pyrrolidines 7a and 25a were correlated with the dihedral angle N(pyrrolidine)-C-C-N(acetamide). A systematic conformational analysis of the potent but flexible kappa agonist 2 showed that a dihedral angle of 168 degrees (as in 25a) is energetically more disfavored than a dihedral angle of 58 degrees (7a). However, even the conformation with a dihedral angle of 58 degrees does not represent an energy minimum, which might explain the reduced kappa affinity of 7a.
双环酮 4 的还原胺化反应具有立体选择性,生成endo-构型的胺,这些胺可以转化为酰胺 7-10。只有在 1,4-二氮杂双环[3.3.1]壬烷系统的两个 N 原子失活后,才能成功合成具有外消旋氨基部分的非对映异构体 25。带有 N-4-对甲苯磺酰基部分的 N-1-氧化物 19 是关键的中间体,它允许在构型反转的情况下,通过 SN2 取代用NaN3取代。endo-构型的吡咯烷 7a(WMS-1302)对κ受体的亲和力为 73 nM,而外消旋的非对映异构体 25a 在κ受体上几乎没有活性(Ki > 1 microM)。用其他酰基和磺酰基取代 3,4-二氯苯乙酰基部分表明,这对于高 κ 亲和力是必需的。构象受限的吡咯烷 7a 和 25a 的 κ 受体亲和力与吡咯烷氮(C-C-N(乙酰胺))的二面角相关。对强但灵活的 κ 激动剂 2 的系统构象分析表明,168 度的二面角(如 25a 中)在能量上比 58 度的二面角(7a)更不利。然而,即使是具有 58 度二面角的构象也不是能量最低的,这可能解释了 7a 的 κ 亲和力降低。